Cite
HARVARD Citation
Ritter, E. et al. (2021). Higher Maintenance Adalimumab Trough Levels are Associated With Achievement of Advanced Remission Targets in Patients With Inflammatory Bowel Disease. Journal of clinical gastroenterology. 55 (9), p. . [Online].